Press-release for stocks for sny

for symbols : Sny

save search

First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
ABT | News | $106.96 -0.59% 2.6M

Health Technology

| 0.0% | O: -1.04% H: 0.0% C: 0.0%
PRGO | $30.69 0.66% 350K

Health Technology

| 0.0% | O: 0.1% H: 0.0% C: 0.0%
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| 0.0% | O: -1.02% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for

Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
SNY | News | $46.765 -1.94% 950K

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
REGN | News | $909.39 0.23% 210K

Health Technology

| 0.0% | O: -0.11% H: 0.0% C: 0.0%
asco tumors treatment blood for

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.415 -7.12% 730K

Health Technology

| 0.0% | O: -5.77% H: 0.0% C: 0.0%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| 0.0% | O: 0.24% H: 0.0% C: 0.0%
business update for financial results

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K

Health Technology

| 1.7% | O: 1.7% H: 0.0% C: 0.0%
first drug authorized food depression treatment clearance for therapeutics

Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
SNY | News | $46.765 -1.94% 950K

Health Technology

| 1.7% | O: 1.7% H: 0.0% C: 0.0%
drug candidate treatment for trial response

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K

Health Technology

| 2.56% | O: 0.85% H: 0.0% C: 0.0%
pharma cancer for

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $30.69 0.66% 350K

Health Technology

| 1.5% | O: -0.4% H: 3.01% C: 2.94%
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| 3.25% | O: 0.83% H: 1.35% C: 1.2%
ABT | News | $106.96 -0.59% 2.6M

Health Technology

| 1.12% | O: -0.75% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

Health Technology

| 3.41% | O: 0.82% H: 0.0% C: 0.0%
first treatment for

Quebec's INESSS recommends BEYFORTUS for the prevention of RSV for all infants 8 months of age and younger(1)
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 480

Health Technology

| 1.67% | O: 0.0% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

Health Technology

| 1.53% | O: -1.81% H: 0.0% C: 0.0%
beyfortus for rsv

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
Published: 2024-04-17 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $94.25 480

Health Technology

| 2.32% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $46.765 -1.94% 950K

Health Technology

| 2.59% | O: 1.05% H: 0.0% C: 0.0%
sclerosis for potential

World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"
Published: 2024-04-17 (Crawled : 04:00) - prnewswire.com
SNYNF | News | $94.25 480

Health Technology

| 2.32% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $46.765 -1.94% 950K

Health Technology

| 2.59% | O: 1.05% H: 0.0% C: 0.0%
BMRN | $91.405 -0.71% 700K

Health Technology

| 1.33% | O: 0.26% H: 0.0% C: 0.0%
day bleeding world for

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | $30.69 0.66% 350K

Health Technology

| -2.53% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| -0.69% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $106.96 -0.59% 2.6M

Health Technology

| -3.46% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $46.765 -1.94% 950K

Health Technology

| -0.73% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 480

Health Technology

| 1.68% | O: 2.24% H: 0.0% C: -0.8%
PRGO | $30.69 0.66% 350K

Health Technology

| -2.9% | O: 0.96% H: 1.17% C: 0.16%
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| -1.88% | O: -0.48% H: 0.0% C: 0.0%
ABT | News | $106.96 -0.59% 2.6M

Health Technology

| -3.25% | O: 0.09% H: 0.16% C: -0.7%
SNY | News | $46.765 -1.94% 950K

Health Technology

| 0.29% | O: 0.84% H: 0.0% C: 0.0%
for

FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 480

Health Technology

| -1.93% | O: -1.77% H: 0.0% C: -1.81%
PRGO | $30.69 0.66% 350K

Health Technology

| -3.05% | O: -0.22% H: 0.8% C: 0.06%
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| -3.69% | O: -1.84% H: 0.0% C: 0.0%
ABT | News | $106.96 -0.59% 2.6M

Health Technology

| -2.29% | O: -0.37% H: 1.42% C: 1.37%
SNY | News | $46.765 -1.94% 950K

Health Technology

| -3.16% | O: -3.44% H: 0.0% C: 0.0%
fda for

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Published: 2024-04-03 (Crawled : 16:00) - globenewswire.com
SNY | News | $46.765 -1.94% 950K

Health Technology

| -1.34% | O: 0.69% H: 0.0% C: 0.0%
health als granted canada

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $30.69 0.66% 350K

Health Technology

| -2.65% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| -5.12% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $106.96 -0.59% 2.6M

Health Technology

| -3.95% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $46.765 -1.94% 950K

Health Technology

| -1.34% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE
Published: 2024-04-03 (Crawled : 12:00) - prnewswire.com
SNY | News | $46.765 -1.94% 950K

Health Technology

| -1.34% | O: 0.69% H: 0.0% C: 0.0%
patent dpx international

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - prnewswire.com
LLY | News | $735.1 -1.42% 1.2M

Health Technology

| -4.85% | O: -2.79% H: 1.32% C: 1.18%
SNY | News | $46.765 -1.94% 950K

Health Technology

| -3.5% | O: -1.14% H: 0.02% C: -1.06%
review cancer treatment advanced china

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - globenewswire.com
LLY | News | $735.1 -1.42% 1.2M

Health Technology

| -4.85% | O: -2.79% H: 1.32% C: 1.18%
SNY | News | $46.765 -1.94% 950K

Health Technology

| -3.5% | O: -1.14% H: 0.02% C: -1.06%
HCM | $18.34 0.49% 38K

Health Technology

| 9.31% | O: 0.21% H: 1.49% C: -0.06%
treatment advanced china

FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K

Health Technology

| Email alert Add to watchlist
ABT | News | $106.96 -0.59% 2.6M

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| Email alert Add to watchlist
PRGO | $30.69 0.66% 350K

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 480

Health Technology